Why the study?
Does dexmedetomidine improve hemodynamics and safety in patients who have undergone cardiac surgery?
Population
1,730 patients who have undergone cardiac surgery (pooled from 18 RCTs)
Comparison
Dexmedetomidine vs Any other treatment without dexmedetomidine
Design
Meta-analysis
Authors
Loading...
Supports dexmedetomidine to lower hemodynamic risks after cardiac surgery; confirms safety across aggregated RCTs.
Does dexmedetomidine improve hemodynamics and safety in patients who have undergone cardiac surgery?
In cardiac surgery patients, dexmedetomidine effectively controls hemodynamics and reduces tachycardia, ICU stay, and delirium, though it is associated with an increased risk of bradycardia.
Wang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: